Genetic discovery and risk characterization in type 2 diabetes across diverse populations

Summary: Genomic discovery and characterization of risk loci for type 2 diabetes (T2D) have been conducted primarily in individuals of European ancestry. We conducted a multiethnic genome-wide association study of T2D among 53,102 cases and 193,679 control subjects from African, Hispanic, Asian, Nat...

Full description

Bibliographic Details
Main Authors: Linda M. Polfus, Burcu F. Darst, Heather Highland, Xin Sheng, Maggie C.Y. Ng, Jennifer E. Below, Lauren Petty, Stephanie Bien, Xueling Sim, Wei Wang, Pierre Fontanillas, Yesha Patel, Michael Preuss, Claudia Schurmann, Zhaohui Du, Yingchang Lu, Suhn K. Rhie, Joseph M. Mercader, Teresa Tusie-Luna, Clicerio González-Villalpando, Lorena Orozco, Cassandra N. Spracklen, Brian E. Cade, Richard A. Jensen, Meng Sun, Yoonjung Yoonie Joo, Ping An, Lisa R. Yanek, Lawrence F. Bielak, Salman Tajuddin, Aude Nicolas, Guanjie Chen, Laura Raffield, Xiuqing Guo, Wei-Min Chen, Girish N. Nadkarni, Mariaelisa Graff, Ran Tao, James S. Pankow, Martha Daviglus, Qibin Qi, Eric A. Boerwinkle, Simin Liu, Lawrence S. Phillips, Ulrike Peters, Chris Carlson, Lynne R. Wikens, Loic Le Marchand, Kari E. North, Steven Buyske, Charles Kooperberg, Ruth J.F. Loos, Daniel O. Stram, Christopher A. Haiman
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:HGG Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666247721000105
id doaj-dbef0a520b5d4bda84a828de1df9808d
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Linda M. Polfus
Burcu F. Darst
Heather Highland
Xin Sheng
Maggie C.Y. Ng
Jennifer E. Below
Lauren Petty
Stephanie Bien
Xueling Sim
Wei Wang
Pierre Fontanillas
Yesha Patel
Michael Preuss
Claudia Schurmann
Zhaohui Du
Yingchang Lu
Suhn K. Rhie
Joseph M. Mercader
Teresa Tusie-Luna
Clicerio González-Villalpando
Lorena Orozco
Cassandra N. Spracklen
Brian E. Cade
Richard A. Jensen
Meng Sun
Yoonjung Yoonie Joo
Ping An
Lisa R. Yanek
Lawrence F. Bielak
Salman Tajuddin
Aude Nicolas
Guanjie Chen
Laura Raffield
Xiuqing Guo
Wei-Min Chen
Girish N. Nadkarni
Mariaelisa Graff
Ran Tao
James S. Pankow
Martha Daviglus
Qibin Qi
Eric A. Boerwinkle
Simin Liu
Lawrence S. Phillips
Ulrike Peters
Chris Carlson
Lynne R. Wikens
Loic Le Marchand
Kari E. North
Steven Buyske
Charles Kooperberg
Ruth J.F. Loos
Daniel O. Stram
Christopher A. Haiman
spellingShingle Linda M. Polfus
Burcu F. Darst
Heather Highland
Xin Sheng
Maggie C.Y. Ng
Jennifer E. Below
Lauren Petty
Stephanie Bien
Xueling Sim
Wei Wang
Pierre Fontanillas
Yesha Patel
Michael Preuss
Claudia Schurmann
Zhaohui Du
Yingchang Lu
Suhn K. Rhie
Joseph M. Mercader
Teresa Tusie-Luna
Clicerio González-Villalpando
Lorena Orozco
Cassandra N. Spracklen
Brian E. Cade
Richard A. Jensen
Meng Sun
Yoonjung Yoonie Joo
Ping An
Lisa R. Yanek
Lawrence F. Bielak
Salman Tajuddin
Aude Nicolas
Guanjie Chen
Laura Raffield
Xiuqing Guo
Wei-Min Chen
Girish N. Nadkarni
Mariaelisa Graff
Ran Tao
James S. Pankow
Martha Daviglus
Qibin Qi
Eric A. Boerwinkle
Simin Liu
Lawrence S. Phillips
Ulrike Peters
Chris Carlson
Lynne R. Wikens
Loic Le Marchand
Kari E. North
Steven Buyske
Charles Kooperberg
Ruth J.F. Loos
Daniel O. Stram
Christopher A. Haiman
Genetic discovery and risk characterization in type 2 diabetes across diverse populations
HGG Advances
Type 2 Diabetes
Genetic Risk Score
author_facet Linda M. Polfus
Burcu F. Darst
Heather Highland
Xin Sheng
Maggie C.Y. Ng
Jennifer E. Below
Lauren Petty
Stephanie Bien
Xueling Sim
Wei Wang
Pierre Fontanillas
Yesha Patel
Michael Preuss
Claudia Schurmann
Zhaohui Du
Yingchang Lu
Suhn K. Rhie
Joseph M. Mercader
Teresa Tusie-Luna
Clicerio González-Villalpando
Lorena Orozco
Cassandra N. Spracklen
Brian E. Cade
Richard A. Jensen
Meng Sun
Yoonjung Yoonie Joo
Ping An
Lisa R. Yanek
Lawrence F. Bielak
Salman Tajuddin
Aude Nicolas
Guanjie Chen
Laura Raffield
Xiuqing Guo
Wei-Min Chen
Girish N. Nadkarni
Mariaelisa Graff
Ran Tao
James S. Pankow
Martha Daviglus
Qibin Qi
Eric A. Boerwinkle
Simin Liu
Lawrence S. Phillips
Ulrike Peters
Chris Carlson
Lynne R. Wikens
Loic Le Marchand
Kari E. North
Steven Buyske
Charles Kooperberg
Ruth J.F. Loos
Daniel O. Stram
Christopher A. Haiman
author_sort Linda M. Polfus
title Genetic discovery and risk characterization in type 2 diabetes across diverse populations
title_short Genetic discovery and risk characterization in type 2 diabetes across diverse populations
title_full Genetic discovery and risk characterization in type 2 diabetes across diverse populations
title_fullStr Genetic discovery and risk characterization in type 2 diabetes across diverse populations
title_full_unstemmed Genetic discovery and risk characterization in type 2 diabetes across diverse populations
title_sort genetic discovery and risk characterization in type 2 diabetes across diverse populations
publisher Elsevier
series HGG Advances
issn 2666-2477
publishDate 2021-04-01
description Summary: Genomic discovery and characterization of risk loci for type 2 diabetes (T2D) have been conducted primarily in individuals of European ancestry. We conducted a multiethnic genome-wide association study of T2D among 53,102 cases and 193,679 control subjects from African, Hispanic, Asian, Native Hawaiian, and European population groups in the Population Architecture Genomics and Epidemiology (PAGE) and Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortia. In individuals of African ancestry, we discovered a risk variant in the TGFB1 gene (rs11466334, risk allele frequency (RAF) = 6.8%, odds ratio [OR] = 1.27, p = 2.06 × 10−8), which replicated in independent studies of African ancestry (p = 6.26 × 10−23). We identified a multiethnic risk variant in the BACE2 gene (rs13052926, RAF = 14.1%, OR = 1.08, p = 5.75 × 10−9), which also replicated in independent studies (p = 3.45 × 10−4). We also observed a significant difference in the performance of a multiethnic genetic risk score (GRS) across population groups (pheterogeneity = 3.85 × 10−20). Comparing individuals in the top GRS risk category (40%–60%), the OR was highest in Asians (OR = 3.08) and European (OR = 2.94) ancestry populations, followed by Hispanic (OR = 2.39), Native Hawaiian (OR = 2.02), and African ancestry (OR = 1.57) populations. These findings underscore the importance of genetic discovery and risk characterization in diverse populations and the urgent need to further increase representation of non-European ancestry individuals in genetics research to improve genetic-based risk prediction across populations.
topic Type 2 Diabetes
Genetic Risk Score
url http://www.sciencedirect.com/science/article/pii/S2666247721000105
work_keys_str_mv AT lindampolfus geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT burcufdarst geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT heatherhighland geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT xinsheng geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT maggiecyng geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT jenniferebelow geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT laurenpetty geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT stephaniebien geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT xuelingsim geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT weiwang geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT pierrefontanillas geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT yeshapatel geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT michaelpreuss geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT claudiaschurmann geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT zhaohuidu geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT yingchanglu geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT suhnkrhie geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT josephmmercader geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT teresatusieluna geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT cliceriogonzalezvillalpando geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT lorenaorozco geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT cassandranspracklen geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT brianecade geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT richardajensen geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT mengsun geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT yoonjungyooniejoo geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT pingan geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT lisaryanek geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT lawrencefbielak geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT salmantajuddin geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT audenicolas geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT guanjiechen geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT lauraraffield geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT xiuqingguo geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT weiminchen geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT girishnnadkarni geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT mariaelisagraff geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT rantao geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT jamesspankow geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT marthadaviglus geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT qibinqi geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT ericaboerwinkle geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT siminliu geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT lawrencesphillips geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT ulrikepeters geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT chriscarlson geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT lynnerwikens geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT loiclemarchand geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT karienorth geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT stevenbuyske geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT charleskooperberg geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT ruthjfloos geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT danielostram geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
AT christopherahaiman geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations
_version_ 1721479870146412544
spelling doaj-dbef0a520b5d4bda84a828de1df9808d2021-05-04T07:33:10ZengElsevierHGG Advances2666-24772021-04-0122100029Genetic discovery and risk characterization in type 2 diabetes across diverse populationsLinda M. Polfus0Burcu F. Darst1Heather Highland2Xin Sheng3Maggie C.Y. Ng4Jennifer E. Below5Lauren Petty6Stephanie Bien7Xueling Sim8Wei Wang9Pierre Fontanillas10Yesha Patel11Michael Preuss12Claudia Schurmann13Zhaohui Du14Yingchang Lu15Suhn K. Rhie16Joseph M. Mercader17Teresa Tusie-Luna18Clicerio González-Villalpando19Lorena Orozco20Cassandra N. Spracklen21Brian E. Cade22Richard A. Jensen23Meng Sun24Yoonjung Yoonie Joo25Ping An26Lisa R. Yanek27Lawrence F. Bielak28Salman Tajuddin29Aude Nicolas30Guanjie Chen31Laura Raffield32Xiuqing Guo33Wei-Min Chen34Girish N. Nadkarni35Mariaelisa Graff36Ran Tao37James S. Pankow38Martha Daviglus39Qibin Qi40Eric A. Boerwinkle41Simin Liu42Lawrence S. Phillips43Ulrike Peters44Chris Carlson45Lynne R. Wikens46Loic Le Marchand47Kari E. North48Steven Buyske49Charles Kooperberg50Ruth J.F. Loos51Daniel O. Stram52Christopher A. Haiman53Department of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USA; Corresponding authorDepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USADepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USADivision of Genetic Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USAThe Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USAThe Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USAAdaptive Biotechnologies Corporation, Seattle, WA, USASaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore23andMe, Sunnyvale, CA, USA23andMe, Sunnyvale, CA, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USAIcahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, New York, NY, USAIcahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, New York, NY, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USADivision of Genetic Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USADepartment of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, CA, USAProgram in Metabolism, Broad Institute, Cambridge, MA, USAUnidad de Biología Molecular y Medicina Genómica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Universidad Nacional Autónoma de Mexico, Mexico City, MexicoCentro de Estudios en Diabetes, Unidad de Investigacion en Diabetes y Riesgo Cardiovascular, Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Pública, Mexico City, MexicoInstituto Nacional de Medicina Genómica, Mexico City, MexicoDepartment of Biostatistics and Epidemiology, University of Massachusetts, Amherst, MA, USADivision of Sleep and Circadian Disorders, Brigham and Women’s Hospital, Boston, MA, USACardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USAWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK, USADivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USADivision of Statistical Genomics, School of Medicine, Washington University, St. Louis, MO, USADepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USALaboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore, MD, USALaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USACenter for Research on Genomics and Global Health, National Human Genome Institute, National Institutes of Health, Bethesda, MD, USADepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAInstitute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USADepartment of Public Health Sciences and Center for Public Health Genomics, University of Virginia School of Medicine, Charlottesville, VA, USAIcahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, New York, NY, USADepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USADepartment of Biostatistics, Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USADivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USAInstitute for Minority Health Research, University of Illinois Chicago, Chicago, IL, USACenter for Population Cohorts, Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USAHuman Genetics Center, University of Texas Health Science Center, Houston, TX, USASchool of Public Health, Brown University, Providence, RI, USAAtlanta VA Medical Center, Decatur, GA, USA; Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USADivision of Public Health Sciences, University of Washington, Department of Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, USADivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USAUniversity of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USAUniversity of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USADepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USADepartment of Statistics, Rutgers University, Piscataway, NJ, USADivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USAIcahn School of Medicine at Mount Sinai, The Mindich Child Health and Development Institute, The Charles Bronfman Institute for Personalized Medicine, New York, NY, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USA; Corresponding authorSummary: Genomic discovery and characterization of risk loci for type 2 diabetes (T2D) have been conducted primarily in individuals of European ancestry. We conducted a multiethnic genome-wide association study of T2D among 53,102 cases and 193,679 control subjects from African, Hispanic, Asian, Native Hawaiian, and European population groups in the Population Architecture Genomics and Epidemiology (PAGE) and Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortia. In individuals of African ancestry, we discovered a risk variant in the TGFB1 gene (rs11466334, risk allele frequency (RAF) = 6.8%, odds ratio [OR] = 1.27, p = 2.06 × 10−8), which replicated in independent studies of African ancestry (p = 6.26 × 10−23). We identified a multiethnic risk variant in the BACE2 gene (rs13052926, RAF = 14.1%, OR = 1.08, p = 5.75 × 10−9), which also replicated in independent studies (p = 3.45 × 10−4). We also observed a significant difference in the performance of a multiethnic genetic risk score (GRS) across population groups (pheterogeneity = 3.85 × 10−20). Comparing individuals in the top GRS risk category (40%–60%), the OR was highest in Asians (OR = 3.08) and European (OR = 2.94) ancestry populations, followed by Hispanic (OR = 2.39), Native Hawaiian (OR = 2.02), and African ancestry (OR = 1.57) populations. These findings underscore the importance of genetic discovery and risk characterization in diverse populations and the urgent need to further increase representation of non-European ancestry individuals in genetics research to improve genetic-based risk prediction across populations.http://www.sciencedirect.com/science/article/pii/S2666247721000105Type 2 DiabetesGenetic Risk Score